sameAs
Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative EffortStem cells and growth factors in wound healingHeat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs)Synthesis and Evaluation of Biological Activity of Antimicrobial--Pro-Proliferative Peptide ConjugatesIncreased migratory properties of aortal smooth muscle cells exposed to calcitriol in cultureEx vivo apoptotic potential of peripheral blood mononuclear cells of the elderly human subject.CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.Islet cell transplant and the incorporation of Tregs.Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoidInhibition of human and yeast 20S proteasome by analogues of trypsin inhibitor SFTI-1Improved coating of pancreatic islets with regulatory T cells to create local immunosuppression by using the biotin-polyethylene glycol-succinimidyl valeric acid ester molecule.Report from the second cytomegalovirus and immunosenescence workshop.Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary ReportAdministration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.Treatment of graft-versus-host disease with naturally occurring T regulatory cells.Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.Recent developments in the synthesis and biological activity of muramylpeptides.Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications.FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells.Influence of pharmacological immunomodulatory agents on CD4(+)CD25(high)FoxP3(+) T regulatory cells in humans.Clinical application of regulatory T cells in type 1 diabetes.Adipose tissue-derived stem cells in clinical applications.Hurdles in therapy with regulatory T cells.Cell-Based Therapies with T Regulatory Cells.New conjugates of mycophenolic acid and their antiproliferative activity.Synthesis and antiproliferative activity of conjugates of adenosine with muramyl dipeptide and nor-muramyl dipeptide derivatives.Fluorescent analogs of trypsin inhibitor SFTI-1 isolated from sunflower seeds--synthesis and applications.Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes.Synthesis and biological activity of mycophenolic acid-amino acid derivatives.Effect of enoxaparin and onion extract on human skin fibroblast cell line - therapeutic implications for the treatment of keloids.Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives.Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections.Biological activity of conjugates of muramyl dipeptides with batracylin derivatives.Partial characterization of human choriocarcinoma cell line JAR cells in regard to oxidative stress.Changes in physicochemical properties of microtubules lead to the formation of a single spherical structure of mitochondrial assembly enveloping nuclear chromatins.CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients.Luteal phase of the menstrual cycle in young healthy women is associated with decline in interleukin 2 levels.
P50
Q26773299-927144CF-D19F-414E-8D2A-C60C655AB7BEQ26798224-CF9D8962-6E4E-44D4-B191-EF13D080CA51Q28069922-3AF7C9C3-CCEF-4645-8D8E-DFC1466F7ECCQ28550329-BD3EBD3C-311A-40CF-83E5-735EE08431FDQ28578267-67F66332-DCFD-4DCF-A428-03C078583B8BQ30837014-162CBEC6-E577-4FD5-AD3A-EF964B4CAB6FQ33205892-39FD3832-60A0-463A-A412-DD2F24E97D27Q34729072-E7A331A5-41F6-4363-8C46-5D4B6F942B33Q34923028-271A70F6-E135-4BBA-AD2F-8578887EA586Q35107386-44C79526-1EF5-418D-9333-A955F89B7480Q35226604-07FAFF9B-5A78-4F51-851B-357AB0032C1AQ35568719-1519B2FA-E6C1-4884-9FBD-2A2F4348BDF5Q35674011-833B1724-5DC0-4B6E-99D2-BE1AC4FEA6B8Q36181380-042C7BA8-9A4D-46B2-A47E-6377CC309FF9Q37294572-2C24D7A7-DA33-4797-A955-9871C99DF074Q37321716-5F42770D-CA32-4BEB-B906-A219DE39AFADQ37394828-A202CD95-C8E1-4202-8974-B86D7AFE889DQ37460801-1FA5E06E-7CA6-4A48-9C00-A663FD95D02BQ37694801-F9C19F02-17AC-4CA3-8962-315F6DFB9738Q37875165-1FFF029B-7A57-4BD6-A875-20B81C22FE7EQ38083439-733BC391-0B2C-4140-B980-D88A773CE0CCQ38083441-BB2DA530-A95F-4D7F-BA66-844E2AE92FD5Q38090198-66691EE6-2B6A-450F-873C-2B59C8E9134EQ38102783-48A4EBC2-2669-48B0-ADFA-9CF4546C67A8Q38126956-3F58F97B-5D90-4C9D-A4AA-5699AA53F171Q38583881-8DFA8E79-AF4E-49B0-961D-4C6871F6ACDCQ38766028-48C7EA37-7BC1-49E0-87F5-3CE0F39A6460Q38768269-10DBAC30-F3F2-47FA-BD3E-B31654E8059DQ38986101-A40D79D2-97D1-488C-A828-1933664B1C30Q39056052-4B736B49-824B-4837-B0FA-C7A031277361Q39074102-F34C7629-6DBC-4A7B-80D4-D8F92EA69713Q39079816-DC882B0E-678D-476E-B93E-E917F558D98EQ39090572-99D6DDFF-FE2F-4C8E-8279-719D551A221FQ39343537-D1336784-03A3-4A29-A03D-EEC05E9A08D6Q40362665-E0DD1C09-3C19-48D2-A60C-A222993FD12FQ40470503-E727225E-48E7-4DE5-8A1A-548FBA618293Q40476095-A6EC5D9A-B48E-4F67-B850-36C61F896D5BQ40483923-B3C96758-9454-4A5F-9C98-F579A78DD806Q40575410-301371AE-2218-4E7F-AC30-6C0C116C45A9Q40792136-02524F3D-3A3D-4DF9-913F-057F19588F04
P50
description
Polish researcher, immunologist
@en
Pools arts
@nl
médicu polacu
@ast
polnischer Arzt
@de
polski lekarz, naukowiec, immunolog
@pl
name
Piotr Trzonkowski
@ast
Piotr Trzonkowski
@ca
Piotr Trzonkowski
@de
Piotr Trzonkowski
@en
Piotr Trzonkowski
@es
Piotr Trzonkowski
@fr
Piotr Trzonkowski
@ga
Piotr Trzonkowski
@it
Piotr Trzonkowski
@nl
Piotr Trzonkowski
@pl
type
label
Piotr Trzonkowski
@ast
Piotr Trzonkowski
@ca
Piotr Trzonkowski
@de
Piotr Trzonkowski
@en
Piotr Trzonkowski
@es
Piotr Trzonkowski
@fr
Piotr Trzonkowski
@ga
Piotr Trzonkowski
@it
Piotr Trzonkowski
@nl
Piotr Trzonkowski
@pl
prefLabel
Piotr Trzonkowski
@ast
Piotr Trzonkowski
@ca
Piotr Trzonkowski
@de
Piotr Trzonkowski
@en
Piotr Trzonkowski
@es
Piotr Trzonkowski
@fr
Piotr Trzonkowski
@ga
Piotr Trzonkowski
@it
Piotr Trzonkowski
@nl
Piotr Trzonkowski
@pl
P214
P106
P1153
6701779453
P1412
P1559
Piotr Trzonkowski
@pl
P21
P214
P27
P31
P3124
P496
0000-0001-5287-5210
P569
1974-01-01T00:00:00Z
P734
P735
P7859
viaf-165430696